Clinical trial
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
NCT04314167 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 28, 2020
- Completion date
- March 1, 2024
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypercholesterolemia, insulin resistance, insulin secretion